S. Kaul

470 total citations
13 papers, 240 citations indexed

About

S. Kaul is a scholar working on Immunology and Allergy, Dermatology and Physiology. According to data from OpenAlex, S. Kaul has authored 13 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology and Allergy, 7 papers in Dermatology and 7 papers in Physiology. Recurrent topics in S. Kaul's work include Food Allergy and Anaphylaxis Research (12 papers), Allergic Rhinitis and Sensitization (12 papers) and Asthma and respiratory diseases (7 papers). S. Kaul is often cited by papers focused on Food Allergy and Anaphylaxis Research (12 papers), Allergic Rhinitis and Sensitization (12 papers) and Asthma and respiratory diseases (7 papers). S. Kaul collaborates with scholars based in Germany, Switzerland and Austria. S. Kaul's co-authors include Stefan Vieths, D. Lüttkopf, Ronald van Ree, Andreas Hoffmann, Lothar Vogel, Thomas M. Kündig, Barbara Ballmer‐Weber, Barbara Bohle, K. Fötisch and Andrea Wangorsch and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Clinical & Experimental Allergy.

In The Last Decade

S. Kaul

12 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Kaul Germany 8 224 102 100 13 12 13 240
Cornelia Egger Austria 3 224 1.0× 115 1.1× 82 0.8× 15 1.2× 9 0.8× 4 237
Eloína González Mancebo Spain 6 156 0.7× 89 0.9× 59 0.6× 10 0.8× 8 0.7× 9 198
Ambra Mascheri Italy 9 206 0.9× 127 1.2× 42 0.4× 13 1.0× 10 0.8× 17 247
María Luisa Somoza Spain 10 141 0.6× 100 1.0× 39 0.4× 15 1.2× 13 1.1× 30 284
Christina Oberhuber Austria 8 291 1.3× 153 1.5× 53 0.5× 35 2.7× 14 1.2× 9 330
Susanne Kaul Germany 8 160 0.7× 69 0.7× 96 1.0× 14 1.1× 7 0.6× 25 197
Fiorella Barocci Italy 6 276 1.2× 182 1.8× 31 0.3× 17 1.3× 14 1.2× 8 320
Philipp Fritsche Switzerland 4 193 0.9× 103 1.0× 34 0.3× 17 1.3× 8 0.7× 6 199
Matthew Kwok United Kingdom 9 193 0.9× 46 0.5× 71 0.7× 12 0.9× 9 0.8× 14 218
H.F. Merk Germany 6 166 0.7× 129 1.3× 45 0.5× 22 1.7× 4 0.3× 14 245

Countries citing papers authored by S. Kaul

Since Specialization
Citations

This map shows the geographic impact of S. Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kaul more than expected).

Fields of papers citing papers by S. Kaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kaul. The network helps show where S. Kaul may publish in the future.

Co-authorship network of co-authors of S. Kaul

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kaul. A scholar is included among the top collaborators of S. Kaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kaul. S. Kaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bartel, Detlef, Andreas Bonertz, S. Kaul, et al.. (2023). Allergen-specific immunotherapy and evidence: A European regulatory perspective. PubMed. 7(1). 198–210. 2 indexed citations
3.
Kleine‐Tebbe, Jörg, S. Kaul, & Ralph Mösges. (2019). Allergen immunotherapy phase II trials: Challenges in dose finding. PubMed. 3(1). 1–8. 4 indexed citations
4.
Mahler, Vera, et al.. (2019). What we learned from TAO – 10 years of German therapy allergen ordinance. Allergo Journal International. 28(8). 330–337. 13 indexed citations
5.
Kleine‐Tebbe, Jörg, S. Kaul, & Ralph Mösges. (2018). Allergen-Immuntherapie-Phase II-Studien: Herausforderungen bei der Dosisfindung. Allergologie. 41(9). 407–415.
6.
Vieths, Stefan, et al.. (2017). Minor allergen patterns in birch pollen allergen products—A question of pollen?. Clinical & Experimental Allergy. 47(8). 1079–1091. 2 indexed citations
7.
Kaul, S., et al.. (2012). Die Therapieallergene-Verordnung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 55(3). 351–357. 20 indexed citations
8.
Vieths, Stefan, Domingo Barber, Martin D. Chapman, et al.. (2012). Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies.. PubMed. 2012. 118–34. 24 indexed citations
9.
Kaul, S., et al.. (2011). Regulatory environment for allergen-specific immunotherapy. Allergy. 66(6). 753–764. 40 indexed citations
10.
Kaul, S., et al.. (2006). Mediator release assays based on human or murine immunoglobulin E in allergen standardization. Clinical & Experimental Allergy. 37(1). 141–150. 55 indexed citations
11.
Ballmer‐Weber, Barbara, Andrea Wangorsch, Barbara Bohle, et al.. (2005). Component‐resolved in vitro diagnosis in carrot allergy: Does the use of recombinant carrot allergens improve the reliability of the diagnostic procedure?. Clinical & Experimental Allergy. 35(7). 970–978. 58 indexed citations
12.
Kaul, S., et al.. (2003). Mediator release assays based on human or murine IgE in allergen standardization. Journal of Allergy and Clinical Immunology. 111(2). S243–S243. 3 indexed citations
13.
Kaul, S., et al.. (2001). [Mediator release assay of rat basophil leukemia cells as alternative for passive cutaneous anaphylaxis testing (PCA) in laboratory animals].. PubMed. 18(1). 55–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026